Alterity Therapeutics Ltd
ATHE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001131343
In the last 90 days, Alterity Therapeutics Ltd insiders filed 1 open-market purchase and 0 sales; 21 institutions reported holding it in 13F filings for Q2 2026, worth $2.12M in total; no superinvestor holds it.
Other share classesPRNAF
13F holders, Q3 2021
Institutional positions in Alterity Therapeutics Ltd as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 14
- 0 vs. Q2 2021
- Shares held
- 638.4K
- −352.0K (−35.5%) vs. Q2 2021
- Total value
- $808.1K
- −$477.0K (−37.1%) vs. Q2 2021
- New holders
- 4
- 0 more added
- Sold out
- 4
- 3 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ATHE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 21 | $2.12M |
| Q1 2026 | 15 | $1.12M |
| Q4 2025 | 18 | $1.00M |
| Q3 2025 | 16 | $1.26M |
| Q2 2025 | 11 | $906.9K |
| Q1 2025 | 12 | $833.9K |
| Q4 2024 | 13 | $415.9K |
| Q3 2024 | 13 | $148.6K |
| Q2 2024 | 10 | $140.9K |
| Q1 2024 | 10 | $193.8K |
| Q4 2023 | 9 | $226.7K |
| Q3 2023 | 8 | $143.5K |
| Q2 2023 | 7 | $163.2K |
| Q1 2023 | 7 | $260.3K |
| Q4 2022 | 13 | $230.5K |
| Q3 2022 | 9 | $299.0K |
| Q2 2022 | 10 | $441.0K |
| Q1 2022 | 13 | $643.0K |
| Q4 2021 | 11 | $541.0K |
| Q3 2021 | 14 | $808.1K |
| Q2 2021 | 14 | $1.29M |
| Q1 2021 | 12 | $1.45M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Alterity Therapeutics Ltd; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sugarloaf Wealth Management, LLC | 333 | $0 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 375 | $0 | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 61 | $0 | 0.00% | 00.0% | Unchanged |
| American Portfolios Advisors | 83 | $105 | 0.00% | 00.0% | Unchanged |
| Geneos Wealth Management Inc. | 1,167 | $1.00K | 0.00% | 00.0% | Unchanged |
| Optimum Investment Advisors | 927 | $1.00K | 0.00% | +927 | New |
| Wells Fargo & Company | 2,500 | $3.00K | 0.00% | 00.0% | Unchanged |
| Providence Capital Advisors, LLC | 2,000 | $3.00K | 0.00% | +2,000 | New |
| HRT Financial LP | 10,610 | $13.0K | 0.00% | −17,382−62.1% | Reduced |
| Virtu Financial LLC | 11,351 | $14.0K | 0.00% | +11,351 | New |
| Citadel Advisors LLC | 11,761 | $15.0K | 0.00% | −26,219−69.0% | Reduced |
| Geode Capital Management, LLC | 12,128 | $15.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 16,107 | $20.0K | 0.00% | +16,107 | New |
| Morgan Stanley | 568,964 | $723.0K | 0.00% | −59,297−9.4% | Reduced |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −237,903−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −36,937−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −4,658−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |